Literature DB >> 33553119

Scalable Production of Equine Platelet Lysate for Multipotent Mesenchymal Stromal Cell Culture.

A Hagen1, H Lehmann2, S Aurich3, N Bauer4, M Melzer1, J Moellerberndt1, V Patané4, C L Schnabel5, J Burk1.   

Abstract

Translation of multipotent mesenchymal stromal cell (MSC)-based therapies is advancing in human and veterinary medicine. One critical issue is the in vitro culture of MSC before clinical use. Using fetal bovine serum (FBS) as supplement to the basal medium is still the gold standard for cultivation of many cell types including equine MSC. Alternatives are being explored, with substantial success using platelet lysate-supplemented media for human MSC. However, progress lags behind in the veterinary field. The aim of this study was to establish a scalable protocol for equine platelet lysate (ePL) production and to test the ePL in equine MSC culture. Whole blood was harvested into blood collection bags from 20 healthy horses. After checking sample materials for pathogen contamination, samples from 19 animals were included. Platelet concentrates were prepared using a buffy coat method. Platelets, platelet-derived growth factor BB, and transforming growth factor β1 concentrations were increased in the concentrates compared with whole blood or serum (p < 0.05), while white blood cells were reduced (p < 0.05). The concentrates were lysed using freeze/thaw cycles, which eliminated the cells while growth factor concentrations were maintained. Donor age negatively correlated with platelet and growth factor concentrations after processing (p < 0.05). Finally, all lysates were pooled and the ePL was evaluated as culture medium supplement in comparison with FBS, using adipose-derived MSC from four unrelated donor horses. MSC proliferated well in 10% FBS as well as in 10% ePL. However, using 5 or 2.5% ePL entailed highly inconsistent proliferation or loss of proliferation, with significant differences in generation times and confluencies (p < 0.05). MSC expressed the surface antigens CD90, CD44, and CD29, but CD73 and CD105 detection was low in all culture media. Adipogenic and osteogenic differentiation led to similar results in MSC from different culture media. The buffy coat method is useful to produce equine platelet concentrate with increased platelet and reduced white blood cell content in large scales. The ePL obtained supports MSC expansion similar as FBS when used at the same concentration (10%). Further investigations into equine MSC functionality in culture with ePL should follow.
Copyright © 2021 Hagen, Lehmann, Aurich, Bauer, Melzer, Moellerberndt, Patané, Schnabel and Burk.

Entities:  

Keywords:  cell culture; equine; fetal bovine serum; mesenchymal stromal cells; platelet concentrate; platelet lysate

Year:  2021        PMID: 33553119      PMCID: PMC7859354          DOI: 10.3389/fbioe.2020.613621

Source DB:  PubMed          Journal:  Front Bioeng Biotechnol        ISSN: 2296-4185


  92 in total

1.  Suspension of bone marrow-derived undifferentiated mesenchymal stromal cells for repair of superficial digital flexor tendon in race horses.

Authors:  Simone Pacini; Silvia Spinabella; Luisa Trombi; Rita Fazzi; Sara Galimberti; Francesca Dini; Fabio Carlucci; Mario Petrini
Journal:  Tissue Eng       Date:  2007-12

2.  No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients.

Authors:  Mikael Sundin; Olle Ringdén; Berit Sundberg; Silvia Nava; Cecilia Götherström; Katarina Le Blanc
Journal:  Haematologica       Date:  2007-08-01       Impact factor: 9.941

3.  Implantation of bone marrow-derived mesenchymal stem cells demonstrates improved outcome in horses with overstrain injury of the superficial digital flexor tendon.

Authors:  E E Godwin; N J Young; J Dudhia; I C Beamish; R K W Smith
Journal:  Equine Vet J       Date:  2011-05-26       Impact factor: 2.888

4.  Fetal bovine serum alternatives.

Authors:  D W Jayme; D A Epstein; D R Conrad
Journal:  Nature       Date:  1988-08-11       Impact factor: 49.962

Review 5.  Leukocyte-rich PRP for knee osteoarthritis: Current concepts.

Authors:  José Fábio Lana; Alex Macedo; Icaro Lanzoni Gallo Ingrao; Stephany Cares Huber; Gabriel Silva Santos; Maria Helena Andrade Santana
Journal:  J Clin Orthop Trauma       Date:  2019-01-14

6.  Platelet lysate obtained via plateletpheresis performed in standing and awake equine donors.

Authors:  Scarlett M Sumner; Maria C Naskou; Merrilee Thoresen; Ian Copland; John F Peroni
Journal:  Transfusion       Date:  2017-04-25       Impact factor: 3.157

7.  Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells.

Authors:  Katharina Schallmoser; Christina Bartmann; Eva Rohde; Andreas Reinisch; Karl Kashofer; Elke Stadelmeyer; Camilla Drexler; Gerhard Lanzer; Werner Linkesch; Dirk Strunk
Journal:  Transfusion       Date:  2007-08       Impact factor: 3.157

Review 8.  Mesenchymal stem cell therapy in horses: useful beyond orthopedic injuries?

Authors:  Catharina De Schauwer; Gerlinde R Van de Walle; Ann Van Soom; Evelyne Meyer
Journal:  Vet Q       Date:  2013-05-22       Impact factor: 3.320

9.  Comparative Analysis of Different Platelet Lysates and Platelet Rich Preparations to Stimulate Tendon Cell Biology: An In Vitro Study.

Authors:  Franka Klatte-Schulz; Tanja Schmidt; Melanie Uckert; Sven Scheffler; Ulrich Kalus; Markus Rojewski; Hubert Schrezenmeier; Axel Pruss; Britt Wildemann
Journal:  Int J Mol Sci       Date:  2018-01-10       Impact factor: 5.923

10.  Human platelet lysate in mesenchymal stromal cell expansion according to a GMP grade protocol: a cell factory experience.

Authors:  Valentina Becherucci; Luisa Piccini; Serena Casamassima; Silvia Bisin; Valentina Gori; Francesca Gentile; Riccardo Ceccantini; Elena De Rienzo; Barbara Bindi; Paola Pavan; Vanessa Cunial; Elisa Allegro; Stefano Ermini; Francesca Brugnolo; Giuseppe Astori; Franco Bambi
Journal:  Stem Cell Res Ther       Date:  2018-05-02       Impact factor: 6.832

View more
  7 in total

Review 1.  A Review of Fetal Bovine Serum in the Culture of Mesenchymal Stromal Cells and Potential Alternatives for Veterinary Medicine.

Authors:  Cara R Pilgrim; Kiera A McCahill; Jenna G Rops; Jaustin M Dufour; Keith A Russell; Thomas G Koch
Journal:  Front Vet Sci       Date:  2022-05-03

2.  Mesenchymal Stromal Cells Adapt to Chronic Tendon Disease Environment with an Initial Reduction in Matrix Remodeling.

Authors:  Carla U Doll; Sabine Niebert; Janina Burk
Journal:  Int J Mol Sci       Date:  2021-11-26       Impact factor: 5.923

3.  Phospholipid Profiles for Phenotypic Characterization of Adipose-Derived Multipotent Mesenchymal Stromal Cells.

Authors:  Janina Burk; Michaela Melzer; Alina Hagen; Katrin Susanne Lips; Katja Trinkaus; Ariane Nimptsch; Jenny Leopold
Journal:  Front Cell Dev Biol       Date:  2021-12-01

4.  Proliferation and Differentiation of Intestinal Caco-2 Cells Are Maintained in Culture with Human Platelet Lysate Instead of Fetal Calf Serum.

Authors:  Dalanda Wanes; Hassan Y Naim; Franziska Dengler
Journal:  Cells       Date:  2021-11-05       Impact factor: 6.600

5.  Functional properties of equine adipose-derived mesenchymal stromal cells cultured with equine platelet lysate.

Authors:  Alina Hagen; Sabine Niebert; Vivian-Pascal Brandt; Heidrun Holland; Michaela Melzer; Axel Wehrend; Janina Burk
Journal:  Front Vet Sci       Date:  2022-08-09

Review 6.  The dark side of foetal bovine serum in extracellular vesicle studies.

Authors:  Ornella Urzì; Roger Olofsson Bagge; Rossella Crescitelli
Journal:  J Extracell Vesicles       Date:  2022-10

7.  Platelet Lysate for Mesenchymal Stromal Cell Culture in the Canine and Equine Species: Analogous but Not the Same.

Authors:  Alina Hagen; Heidrun Holland; Vivian-Pascal Brandt; Carla U Doll; Thomas C Häußler; Michaela Melzer; Julia Moellerberndt; Hendrik Lehmann; Janina Burk
Journal:  Animals (Basel)       Date:  2022-01-13       Impact factor: 2.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.